Reducing Delay in Vaccination of Children: Logistic Barriers
REDIVAC-LB
The REDIVAC Study-Reducing Delay in Vaccination of Children Study
1 other identifier
interventional
250
1 country
1
Brief Summary
This study will assess the impact of automated reminders for the 6 month and 12 month vaccine visits to increase vaccination in parents experiencing logistic barriers to vaccination.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2018
CompletedFirst Posted
Study publicly available on registry
May 4, 2018
CompletedStudy Start
First participant enrolled
June 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2019
CompletedAugust 7, 2019
August 1, 2018
10 months
March 26, 2018
August 5, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Vaccines received (Electronic Health Record)
Vaccination records from the participants electronic health record will be used to measure vaccines received. Vaccines received is a dichotomous variable indicating if any vaccines were received while enrolled in the study
up to a year of follow up
Secondary Outcomes (1)
Vaccine dose (Electronic Health Record)
up to a year of follow up
Study Arms (2)
Usual Care
NO INTERVENTIONParents will receive usual care for their child at Kaiser Permanente Colorado. This includes recommendations for well child visits at 2, 4, 6 and 12 months of age as well as automated reminders for age eligible children to receive the flu shot during flu season.
Reminders
EXPERIMENTALParents randomized to the reminder arm will receive automated reminders to complete a 6 month and 12 month vaccine visit for their child. They will receive 2 reminders before the child is 6 and 12 months of age and 2 reminders after their child is 6 and 12 months of age. Reminders will not occur if they have received vaccines within the eligible time frame to receive a vaccine or have a visit scheduled. After randomization, participants in the intervention arm will have an opportunity to provide their preference on how they receive reminders (text, phone and/or email). Participants not providing a preference will receive text reminders. If a child is randomized into the study after the child is 7 months of age, the parent will only be eligible for reminders for the 12 month vaccine visit.
Interventions
Automated reminders for the 6 month and 12 month vaccine visits for parents experiencing logistic barriers to vaccination.
Eligibility Criteria
You may qualify if:
- Parents of children less than 11 months of age
- Currently enrolled at Kaiser Permanente Colorado at the time of identification
- The child is missing recommended vaccinations
You may not qualify if:
- Non-english speaking
- diagnosis code indicating parent vaccine refusal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kaiser Permanentelead
- University of Colorado, Denvercollaborator
Study Sites (1)
Kaiser Permanente Colorado Institute for Health Research
Denver, Colorado, 80231, United States
Related Publications (1)
Palmer MJ, Henschke N, Bergman H, Villanueva G, Maayan N, Tamrat T, Mehl GL, Glenton C, Lewin S, Fonhus MS, Free C. Targeted client communication via mobile devices for improving maternal, neonatal, and child health. Cochrane Database Syst Rev. 2020 Jul 14;8(8):CD013679. doi: 10.1002/14651858.CD013679.
PMID: 32813276DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jason Glanz, PhD
Kaiser Permanente
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The Investigator and Analyst will stay blinded to the randomization arm throughout the trial.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 26, 2018
First Posted
May 4, 2018
Study Start
June 1, 2018
Primary Completion
March 31, 2019
Study Completion
March 31, 2019
Last Updated
August 7, 2019
Record last verified: 2018-08